NCT05661162View on ClinicalTrials.gov

"Evaluation of the Effect of the CR500 SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)"

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

May 18, 2021

Study Completion Date

May 18, 2021

Conditions
Knee Osteoarthritis
Interventions
DEVICE

CR 500™ SINGLE-DOSE GEL

CR 500™ SINGLE-DOSE GEL is a hydrogel to be applied to intact skin, useful to attenuate the physiological degeneration of cartilage typical of osteoarthritic processes. The presence of sodium hyaluronate facilitates the movement of joints and tendons for greater mobility and flexibility

Trial Locations (1)

21053

Istituto Clinico Mater Domini Casa di Cura Privata - Gruppo Humanitas, Castellanza

All Listed Sponsors
lead

Contrad Swiss SA

INDUSTRY

NCT05661162 - "Evaluation of the Effect of the CR500 SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)" | Biotech Hunter | Biotech Hunter